See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2022_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 321,775,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 322,010,000 |
| 2 | PropertyPlantAndEquipmentNet | 52,671,000 |
| 3 | remainder_Assets | 75,142,000 |
| 4 | LiabilitiesCurrent | 87,537,000 |
| 5 | LiabilitiesNoncurrent | 294,321,000 |
| 6 | remainder_Liabilities | 31,000,000 |
| 7 | CostOfGoodsAndServicesSold | 26,527,479 |
| 8 | SellingGeneralAndAdministrativeExpense | 177,790,209 |
| 9 | ResearchAndDevelopmentExpense | 12,274,768 |
| 10 | remainder_Expenses | 317,281,983 |
| 11 | remainder_Revenues | 238,333,709 |
| 12 | remainder_NetIncome | -15,330,312 |
| 13 | remainder_ComprehensiveNetIncome | -5,662,247 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 771,598,000 |
| 1 | Liabilities | 412,858,000 |
| 2 | Expenses | 533,874,439 |
| 3 | Revenues | 238,333,709 |
| 4 | StockholdersEquity | 358,740,000 |
| 5 | NetIncome | -310,871,042 |
| 6 | ComprehensiveNetIncome | -313,702,166 |
| 7 | BaseVar | 988,828,354 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.791 |
| 9 | EconomicCapitalRatio | 2.13 |
Edgar->Model Mapping
Feature Distribution
Change over Time
